Skip to main content

Closed

UNCY: Unicycive Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

26thpctl

Volume

0.32×avg

Market Cap

133.77MUSD

P/E Ratio

-2.4TTM

Div Yield

-ann

Unicycive Therapeutics, Inc.

UNCYNASDAQ Capital Market·USD·Closed

Unicycive Therapeutics, Inc.

UNCYNASDAQ·USD·Closed

$5.01

−5.47%

$5.01

−$0.29 (5.47%)

52W Range

26thpctl

Volume

0.32×avg

Mkt Cap

133.77MUSD

P/E

-2.4TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings